seres therapeutics stock prediction

The Score for MCRB is 86 which is 72 above its historic median score of 50 and infers lower risk than normal. MCRB stock forecast Our latest prediction for Seres Therapeutics Incs stock price was made on the June 18 2019 when the stock price was at 261.

Seres Therapeutics Nasdaqgs Mcrb Stock Price Quote Analysis Simply Wall St

The company has a debt-to-equity ratio of.

. Get free stock tools free stock ratings free stock charts and calculate the value of stocks to buy. The current Seres Therapeutics MCRB share price is 905. The Score for MCRB is 50 which is 0 below its historic median score of 50 and infers higher risk than normal.

Is 2751 and for 2031 Mar. According to the issued ratings of 3 analysts in the last year the consensus rating for Seres Therapeutics stock is Buy based on the current 3 buy ratings for MCRB. MCRB stock forecast Our latest prediction for Seres Therapeutics Incs stock price was made on the July 8 2022 when the stock price was at 405.

Seres Therapeutics Stock Forecast 1S9 stock price prediction. The company has a debt-to-equity ratio of. Is 65 for 2026 Mar.

122 rows About the Seres Therapeutics Inc. Seres Therapeutics stock opened at 814 on Friday. The best long-term short-term Seres Therapeutics share price.

Seres Therapeutics has a 12 month low of 250 and a 12 month high of 1169. Seres Therapeutics has a 12 month low of 250 and a 12 month high of 1169. Stock USD 544 041 701 Seres Therapeutics stock price prediction is an act of determining the future value of Seres Therapeutics shares using few different conventional methods such as.

As of 2022 October 17 Monday. In the short term 2weeks MCRBs. Seres Therapeutics Stock Prediction.

Seres Therapeutics Stock Prediction. Seres Therapeutics Stock Prediction. In the short term 2weeks.

Seres Therapeutics Stock Prediction. Seres Therapeutics Stock Prediction. Is 707 for 2023 Mar.

From AI system total return is 303969 from 3779 forecasts. The current Seres Therapeutics MCRB share price is 338. Seres Therapeutics stock opened at 814 on Friday.

Is 1045 for 2027 Mar. Price target in 14 days. Seres Therapeutics Stock Prediction.

Forecast for 2022 Apr. Non-cash charges consisted of stock-based compensation expense of 182 million 36 million related to the amortization of right-of-use assets. - USA Stock USD 324 048 1290 Seres Therapeutics stock price prediction is an act of determining the future value of Seres Therapeutics shares using few different conventional.

Seres Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2b Study of SER-287 to Treat Mild-to-Moderate Ulcerative Colitis 3 weeks ago Business Wire.

Seres Therapeutics Nasdaqgs Mcrb Stock Price Quote Analysis Simply Wall St

Seres Therapeutics Stock The Good And The Challenging Nasdaq Mcrb Seeking Alpha

Novel Antigen Presenting Cell Imparts Treg Dependent Tolerance To Gut Microbiota Nature

Best Biotech Stocks Which Companies Have Growth Potential

The Simplified Comorbidity Index A New Tool For Prediction Of Nonrelapse Mortality In Allo Hct Sciencedirect

Mcrb Seres Therapeutics Inc Stock Overview U S Nasdaq Barron S

Development And Validation Of Clinical Scoring Tool To Predict Outcomes Of Treatment With Vedolizumab In Patients With Ulcerative Colitis Clinical Gastroenterology And Hepatology